Search research articles
Contact Us
Filters
Showing results (181-190 of 225) with videos related to
Page
of 23
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 29, 2024
Systemic delivery of proteins using novel peptides via the sublingual route
Jiamin Wu, Natalie Jones, Lukas Hohenwarter, et al.
Human Gene Therapy
|
September 9, 2004
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation
Colin J D Ross, Jaap Twisk, Janneke M Meulenberg, et al.
NPJ Genomic Medicine
|
May 22, 2021
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
Erika N Scott, Galen E B Wright, Britt I Drögemöller, et al.
The Lancet. Child & Adolescent Health
|
February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study
Diana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Therapeutic Drug Monitoring
|
July 12, 2011
CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study
Sondra VanderVaart, Howard Berger, Johanna Sistonen, et al.
British Journal of Clinical Pharmacology
|
May 20, 2016
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
Folefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Circulation
|
December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
Tarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
The Pharmacogenomics Journal
|
January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
L R Brunham, P J Lansberg, L Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients
Britt I Drögemöller, Beth Brooks, Carol Critchley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 225) with videos related to
Sort By:
Page
of 23
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 29, 2024
Systemic delivery of proteins using novel peptides via the sublingual route
Jiamin Wu, Natalie Jones, Lukas Hohenwarter, et al.
Human Gene Therapy
|
September 9, 2004
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation
Colin J D Ross, Jaap Twisk, Janneke M Meulenberg, et al.
NPJ Genomic Medicine
|
May 22, 2021
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
Erika N Scott, Galen E B Wright, Britt I Drögemöller, et al.
The Lancet. Child & Adolescent Health
|
February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study
Diana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Therapeutic Drug Monitoring
|
July 12, 2011
CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study
Sondra VanderVaart, Howard Berger, Johanna Sistonen, et al.
British Journal of Clinical Pharmacology
|
May 20, 2016
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
Folefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Circulation
|
December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
Tarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
The Pharmacogenomics Journal
|
January 19, 2011
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
L R Brunham, P J Lansberg, L Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2018
Further Investigation of the Role of <i>ACYP2</i> and <i>WFS1</i> Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients
Britt I Drögemöller, Beth Brooks, Carol Critchley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2023
Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial
Etan Orgel, Kristin R Knight, Yueh-Yun Chi, et al.
Page
of 23